c-MYC was elevated suggesting that RRM2-OE-TPC-1 cells may achieve the synergistic activation of multiple proliferative signaling pathways with the help of this transcription factor, accelerating tumor progression (34). The gene discussed is RRM2; the disease is neoplasm.